On February 13, 2025, Sankalp India Foundation achieved a significant milestone in thalassemia and sickle cell disease prevention, enrolling 1,50,000 families in antenatal screening.
This effort, spanning 80 centers across 5 states, has prevented over 142 births of children with hemoglobinopathies, providing families with a healthier future since we started scaling it in July 2023. Early screening remains crucial in breaking the cycle of these genetic conditions and reducing lifelong health burdens.
With the need still immense, Sankalp India Foundation is committed to expanding this life changing program. We call on businesses, institutions, and individuals to support our efforts in scaling up screening and prevention. Increased collaboration, resources, and expertise can help reach more families and create lasting impact.
Together, we can build a healthier and happier future for generations to come